Please consider before continuing:
Of the seven medical conditions formerly used to promote 'stem cells and cloning' to the American public--spinal cord injury, stroke, diabetes, Parkinson's, Alzheimer's, ALS, and Multiple Sclerosis--after two decades of prioritized federal funding by the NIH of embryonic stem cells research, none have been cured. Since 2006, these seven conditions have generated over $1 trillion in revenues for pharmaceuticals. If these seven remain uncured through 2033, marketplace projections expect them to earn the drug industry a further $1.3 trillion.
Please continue: